Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Publication year range
1.
Diabetologia ; 54(1): 190-9, 2011 Jan.
Article in English | MEDLINE | ID: mdl-20957341

ABSTRACT

AIMS/HYPOTHESIS: Inflammation is a common feature in cardiovascular diseases, including diabetes mellitus. In addition to the well-known inflammatory role of cyclo-oxygenase-2 (COX-2), this protein has also been implicated in apoptosis resistance in tumour cells. Vascular smooth muscle cells (VSMC) from diabetic patients are also resistant to apoptosis because of an increased abundance of B cell lymphoma 2 protein (BCL2). In this work, we investigated whether overproduction of COX-2 was involved in the resistance to apoptosis in VSMC from diabetic patients. METHODS: VSMC were obtained from internal mammary arteries from patients who had undergone coronary artery bypass graft surgery. Apoptosis was measured by DNA fragmentation, BCL2 degradation and cytochrome c release. RESULTS: Apoptosis induced by C-reactive protein in cells from non-diabetic patients was mediated by COX-2. VSMC from diabetic patients showed higher basal levels of COX-2 compared with those from non-diabetic patients. Transfection of VSMC from non-diabetic patients with a plasmid containing COX-2 (also known as PTGS2) increased basal production of COX-2 and BCL2 and mimicked the resistance to apoptosis that occurs in diabetic patients. We also found a significant correlation (R = 0.846, p = 0.016) between COX-2 and BCL2 production in arterial rings from diabetic patients measured by confocal microscopy. However, inhibition of COX-2 production by small interfering RNA proved unable to reverse BCL2 production in diabetic VSMC. CONCLUSIONS/INTERPRETATION: These results suggest a link between inflammation (COX-2) and apoptosis resistance (BCL2) in the arteries of diabetic patients. This relationship is not causative and the common production of these two proteins may be co-regulated by shared regulatory elements in diabetes.


Subject(s)
Apoptosis/genetics , Cyclooxygenase 2/metabolism , Diabetes Mellitus/immunology , Diabetes Mellitus/pathology , Muscle, Smooth, Vascular/cytology , Myocytes, Smooth Muscle/cytology , Myocytes, Smooth Muscle/metabolism , Apoptosis/drug effects , Blotting, Western , C-Reactive Protein/pharmacology , Cells, Cultured , Cyclooxygenase 2/genetics , DNA Fragmentation/drug effects , Fluorescent Antibody Technique , Humans , Proto-Oncogene Proteins c-bcl-2/genetics , Proto-Oncogene Proteins c-bcl-2/metabolism , RNA, Small Interfering
2.
Clín. cardiovasc ; 19(2): 68-71, mar. 2001. ilus
Article in Es | IBECS | ID: ibc-15482

ABSTRACT

Actualmente existe entre los cirujanos cardíacos una tendencia en alza para efectuar los procedimientos quirúrgicos cardíacos a través de vías de abordaje menos invasivas, incluyendo el empleo de incisiones limitadas. Se describe una incisión cutánea limitada con realización de una esternotomía completa, que permite el empleo de técnicas e instrumentos quirúrgicos habituales, su rápida y fácil conversión a una exposición "standard" y es fácil de aprender (AU)


Subject(s)
Humans , Sternum/surgery , Thoracic Surgical Procedures/methods , Heart Diseases/surgery , Extracorporeal Circulation , Minimally Invasive Surgical Procedures/methods , Minimally Invasive Surgical Procedures/instrumentation , Thoracic Surgical Procedures/instrumentation
3.
J Cardiovasc Surg (Torino) ; 37(6): 621-2, 1996 Dec.
Article in English | MEDLINE | ID: mdl-9016979

ABSTRACT

A new case of Osteogenesis Imperfecta (OI) suffering ischemic heart disease is reported. The patient was successfully operated on in our Institution and the bibliographic search showed only another case of such an association of diseases successfully treated by surgery. This patient proves that coronary artery surgery procedures are possible when OI complicates the cardiac ischemic syndrome.


Subject(s)
Coronary Artery Bypass , Myocardial Ischemia/surgery , Osteogenesis Imperfecta/complications , Humans , Male , Middle Aged , Myocardial Ischemia/etiology
4.
Rev Esp Cardiol ; 49(5): 386-8, 1996 May.
Article in Spanish | MEDLINE | ID: mdl-8744395

ABSTRACT

A case of aortic valve endocarditis caused by Coxiella burnetii and operated on with success is reported. The patient is doing well at 18 months follow up. Diagnosis of Q-fever endocarditis was made by high antibodies against phase I Coxiella burnetii antigens titration and by demonstration of aortic valvular vegetations by bidimensional echocardiography. Our patient suffered emergency aortic valve substitution due to acute hemodynamic failure and started a long-term treatment with doxycycline and rifampicin. Some interesting aspects about the diagnosis and treatment of this patient are reviewed because long-term follow-up and serological controls are still rare in the literature.


Subject(s)
Endocarditis, Bacterial/etiology , Q Fever/complications , Anti-Bacterial Agents/therapeutic use , Aortic Valve/surgery , Doxycycline/therapeutic use , Drug Therapy, Combination/therapeutic use , Endocarditis, Bacterial/drug therapy , Endocarditis, Bacterial/surgery , Follow-Up Studies , Heart Valve Prosthesis , Humans , Male , Middle Aged , Rifampin/therapeutic use , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...